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Abstract
Rac1 influences a multiplicity of vital cellular- and tissue-level control functions, making it an important candidate for
targeted therapeutics. The activity of the Rho family member Cdc42 has been shown to be modulated by tyrosine
phosphorylation at position 64. We therefore investigated consequences of the point mutations Y64F and Y64D in Rac1.
Both mutations altered cell spreading from baseline in the settings of wild type, constitutively active, or dominant negative
Rac1 expression, and were accompanied by differences in Rac1 targeting to focal adhesions. Rac1-Y64F displayed increased
GTP-binding, increased association with bPIX, and reduced binding with RhoGDI as compared with wild type Rac1. Rac1-
Y64D had less binding to PAK than Rac1-WT or Rac1-64F. In vitro assays demonstrated that Y64 in Rac1 is a target for FAK
and Src. Taken together, these data suggest a mechanism for the regulation of Rac1 activity by non-receptor tyrosine
kinases, with consequences for membrane extension.
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Introduction
Rac1 is a member of the small guanosine triphosphatase Rho
family of proteins which also includes Rho and Cdc42. Rac1 has
been shown to play important roles in a wide variety of cellular
processes, including cytoskeletal reorganization, cell migration, cell
transformation, induction of DNA synthesis, superoxide produc-
tion, and axonal guidance [1–8]. The classical understanding of
the regulation of activity in Rho family members is based upon
two conformations - the GTP-bound or ‘‘active’’ form, and the
GDP-bound or ‘‘inactive’’ form [9]. Changes in Rac1 activation
may be triggered by a variety of extracellular signals including
matrix adhesion, growth factors, cytokines, and endocrine
hormones, and by intracellular signals including cytosolic free
calcium and lipid raft trafficking [10–13]. These signals are
integrated via guanine nucleotide exchange factors (GEFs) which
convert Rac1 from GDP bound to GTP bound form, and
GTPase-activating proteins (GAPs), which convert GTP-bound to
GDP-bound Rac1. Rho GDP-dissociation inhibitor (RhoGDI)
also plays a regulatory role in Rac1 activity. RhoGDI is a cytosolic
protein that associates with Rac1 and can prevent Rac1 from
targeting to the cell membrane. RhoGDI therefore controls the
access of Rac1 to regulatory GEFs and GAPs [14,15].
Interestingly, the function of Rho family proteins may also be
modulated via protein phosphorylation. Protein kinase A (PKA)-
mediated phosphorylation of RhoA on Ser188 was observed both
in vitro and in vivo in natural killer T lymphocytes [16]. This
phosphorylation did not change RhoA GTPase activity or binding
to GTP, but led to the exit of phosphorylated RhoA from the
plasma membranes and an increased presence of the RhoA-
RhoGDI complex in the cytosol. Increased cellular cAMP levels
and PKA activity resulted in morphological changes consistent
with RhoA inhibition. It was therefore suggested that PKA-
mediated phosphorylation of RhoA inhibits Rho activity by
promoting formation of a RhoA-RhoGDI complex. Similarly,
PKA-mediated phosphorylation and a resultant increase in
complex formation with RhoGDI was observed with both RhoA
and Cdc42 in studies of rodent brain [17]. It is not clear whether
Rac1 is a phosphorylation target for PKA, but Kwon et al.
demonstrated phosphorylation of Rac1 on Ser-71 by Akt in
human melanoma cells [18]. This Akt-mediated Rac1 phosphor-
ylation resulted in an approximately 50% reduction in GTP
binding by Rac1, but did not change GTPase activity. In the case
of Cdc42, tyrosine phosphorylation at position 64 was observed
following treatment with epidermal growth factor, and this was
mediated by Src in COS-7 cells [19,20]. Tyrosine-64 was
identified as the major phosphorylation site in these experiments,
but tyrosine phosphorylation on Y64 was not required for Cdc42
activation. Tyrosine phosphorylation on Y64 of Cdc42 also did
not affect its binding with several target/effector proteins including
PAK, ACK2, MRCK, WASP or IQGAP – but increased
association with RhoGDI was noted. Since Cdc42-RhoGDI
interactions are involved in Cdc42-induced cellular transforma-
tion, it was suggested that phosphorylation of Cdc42 led to
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from this earlier work is that protein phosphorylation may serve a
specific role in signal modulation of Rho family GTPases by
altering binding interactions with upstream regulators, with GTP,
and with RhoGDI.
Tyrosine phosphorylation of Rac1 has not been explored to
date, although we have demonstrated that tyrosine phosphoryla-
tion of bPIX is associated with increased binding to Rac1 in vitro,
and augmentation of cell spreading [21]. Given that human Rac1
and Cdc42 share high homology and have the identical amino
acid sequence at residues 61–70 (Figure 1), site-directed mutagen-
esis was used here to investigate the impact of Tyr-64
phosphorylation on cell spreading and the interaction of Rac1
with regulatory and effector proteins. Rac1-Y64F was used to
obviate phosphorylation at this site, while Rac1-Y64D was
employed to mimic the constitutively phosphorylated state.
Strikingly, expression of the Rac1-Y64D mutant greatly inhibited
cell spreading and decreased Rac1 binding to PAK. Expression of
the Rac1-Y64F mutant facilitated cell spreading, while it increased
Rac1 binding to GTP and to Rac1-associated GEFs, and
decreased binding to RhoGDI. Specific interactions in vitro and
in vivo indicated that Rac1 may be a substrate for the non-
receptor tyrosine kinases FAK and Src.
Methods
Cell culture, DNA constructs, and transfection
Mouse embryo fibroblasts (MEFs), obtained from ATCC
(Rockville, MD), and murine fibroblasts homozygous for deletion
of the Src, Yes and Fyn genes (SYF) (a generous gift from Dr.
Philippe Soriano, Mount Sinai School of Medicine of New York
University) were maintained in Dulbecco’s modified medium
(DMEM) (Sigma, St Louis, MO) supplemented with 10% fetal
bovine serum (Atlanta Biological, Atlanta, GA), 2 mM L-
glutamine (Gibco-BRL, Grand Island, NY), penicillin G, strepto-
mycin and amphotericin B (Gibco-BRL). HUVEC from VEC
Technologies (Rensselaer, NY) were maintained in MCDB-131
complete medium (VEC). EGFP-tagged Rac1-WT (wild type),
Rac1-61L and Rac1-17N were gifts from Dr. Klaus Hahn
(University of North Carolina). GST-tagged Rac1-WT , Rac1-
61L, and Rac1-17N were gifts from Dr. Ian Macara (University of
Virginia). Wild-type and kinase dead Src constructs were gifts from
Dr. Uyen Huynh-Do (University of Bern, Switzerland).
EGFP-tagged Rac1-Y64F and Rac1-Y64D mutants were
constructed using the QuikChange Site-directed mutagenesis kit
(Stratagene, La Jolla, CA) with EGFP-Rac1-WT as the template
and the following primer sets: For Rac1-Y64D 59-GGGACA-
CAGCTGGACAAGAAGACGAT GACAGATTGCGTCCCC-
39 and 59-GGGGACGCAATCTGTCATCGTCTTCTT GTC-
CAGCTGTGTCCC-39; and for Rac1-Y64F 59-GGGACAC-
AGCTGGACAAGAAGACTTT GACAGATTGCGTCCCC-39
and 59-GGGGACGCAATCTGTCAAAGTCTTCTT GTCCA-
GCTGTGTCCC-39 GST-tagged Rac1-Y64D and Rac1-Y64F
were constructed with the same primer sets but with GST-Rac1-
WT as the template.
Using EGFP-Rac1-17N as the template, the double mutants
EGFP-Rac1-17N/64D and EGFP-Rac1-17N/64F were con-
structed with the same primer sets. EGFP-Rac1-61L/64D and
EGFP-Rac1-61L/64F were constructed using EGFP-Rac1-61L as
the template and the following primer sets: For 61L64D 59-
GGGACACAGCTGGACTAGAAGACGAT GACAGATTGC-
GTCCCC-39 and 59-GGGGACGCAATCTGTCATCGTCTT-
CTA GTCCAGCTGTGTCCC-39; and for 61L64F 59-GGGA-
CACAGCTGGACTAGAAGACTTT GACAGATTGCGTCC-
CC-39 and 59-GGGGACGCAATCTGTCAAAGTCTTCTA G-
TCCAGCTGTGTCC-39. GST-tagged double mutants were
constructed with the same primer sets but with GST-Rac1-17N
or GST-Rac1-61L as the templates. All new constructs were
confirmed by both restriction enzyme digestion and DNA
sequencing.
The avian FAK kinase domain (amino acids 411–686), and the
Src kinase domain (amino acids 86–536, SH3-SH2-Kinase) [22])
were generated in baculovirus-transfected Hifive insect cells.
Transient transfections were accomplished using Lipofectamine
Plus (Gibco-BRL) and standard product protocols. Briefly, cells
were plated 24 hours before transfection. Cells were washed and
then incubated for 3 hours in serum-free DMEM medium
containing plasmid DNA mixed with Lipofectamine and Plus
reagent. The medium was then replaced with DMEM containing
10% FBS and incubated for 48 hours before cells were prepared
for immunofluorescence or immune replica analysis.
Antibodies
Anti-Rac1 antibodies included mouse monoclonal clone 102
(BD Biosciences, San Diego CA) and rabbit polyclonal clone C-11
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Other primary
antibodies included anti-Src (rabbit polyclonal, Cell Signaling,
Danvers, MA), anti-GFP (rabbit polyclonal, Abcam Inc., Cam-
bridge MA), anti-GST (rabbit polyclonal, Molecular Probes,
Eugene, OR), anti-Flag (rabbit polyclonal, Sigma, St. Louis,
MO), anti-Myc (mouse monoclonal, Santa Cruz Biotechnology,
Inc), anti-phosphotyrosine py20 (BD Biosciences), anti-cleaved
caspase3 (Cell Signaling) and anti-vinculin (mouse monoclonal
clone 7F9, a gift from Dr. Alexey Belkin, University of Maryland,
Baltimore, MD). Horseradish peroxidase-conjugated anti-mouse
Figure 1. Sequence homology for Cdc42 and Rac1. Amino acid sequences are shown for human Cdc42 (top) and Rac1 (bottom). The sequence
identity between the two proteins at aa 61–70 is underlined, Y64 is capitalized, and all tyrosine residues appear in bold type.
doi:10.1371/journal.pone.0028587.g001
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Biochemicals Inc. (Costa Mesa, CA). Affinity-purified and cross-
adsorbed secondary antibodies Cy5-conjugated goat anti-mouse
(H+L) was purchased from Jackson ImmunoResearch Laborato-
ries (West Grove, PA). Rhodamine-conjugated phalloidin for actin
staining were purchased from Molecular Probes (Eugene, OR).
Immunofluorescence and epifluorescence microscopy
Cells were plated on fibronectin-coated glass coverslips for
90 min (HUVEC) to 2 hr (MEF). Cells were then permeabilized
for 2 min with 0.5% Triton X-100 (Fisher Scientific) in 3%
paraformaldehyde (Sigma) followed by fixation with 3% parafor-
maldehyde for 20 min. Antibody incubations were done for
30 min. Cells were observed on an epifluorescence Nikon TE-200
microscope. Images were captured with a Coolsnap HQ camera
(Roper, Duluth, GA) with Openlab software (Improvision,
Lexington, MA).
Cell surface area analysis and kymography
Cell surface area was calculated and analyzed using Openlab
software by making a binary mask from acquired images of the
GFP-labeled transfected cells or the rhodamine-phalloidin-labeled
non-transfected cells.
Kymography analysis of lamellipodial activity was done by
using phase contrast movies of cells spreading on fibronectin-
coated 35 mm glass bottom dishes (Plastek Cultureware, Ashland,
MA, USA). Images were obtained at 20-second intervals for 20
minutes with the system described above. Kymography and
quantitative analysis were accomplished using an original
MATLAB code (Mathworks, Natick, MA).
Analysis of Rac1 localization to focal adhesions
The percentage of focal adhesion area occupied by Rac1 wild-
type or mutants was determined by using an original automation
as previously described [21]. First, a binary mask corresponding to
total focal adhesion area was made from the vinculin images, and
the total focal adhesion area was calculated. Then, a mask
corresponding to regions of Rac1 localization was made. The ratio
of the two binary masks yielded the percentage of focal adhesion
area showing Rac1 colocalization. Optimal spectral separation of
Rac1 and vinculin was achieved by using Cy5-conjugated
secondary antibody to label vinculin in cells expressing EGFP-
Rac1 chimeras.
Rac1 Binding to GTP and Western blotting
These assays were accomplished as previously described [21].
Briefly, the cDNA of the p21-binding domain (PBD) from human
PAK1 (amino acids 67–150) (gift of Keith Burridge, University of
North Carolina) was expressed in E. coli as a glutathione S-
transferase fusion protein, purified, and immobilized on glutathi-
one-sepharose beads [23]. Protein lysates from EGFP, EGFP-
Rac1-wild-type- or EGFP-Rac1-mutant-transfected MEF cells
were obtained two days after transfection. Cells were washed with
ice-cold HEPES buffer and then lysed with lysis buffer (50 mM
Tris (pH 7.6), 500 mM NaCl, 0.5 mM MgCl2, 1% Triton, 0.5%
DOC, 0.1% SDS, 10 mg/ml leupeptin, 10 mg/ml aprotinin,
1 mM PMSF, 0.5 mM sodium vanadate). 50 mg of GST-PBD
immobilized on glutathione-sepharose beads was added to
approximately 800 mg of protein from cell lysates, and incubated
at 4
oC with rotation for 60 minutes. Beads were then washed,
boiled in sample buffer [24], and proteins were subjected to SDS-
PAGE and transferred to nitrocellulose membranes. GST-PBD
bound active Rac1 (in the GTP-bound form) was detected by
Western blotting using a monoclonal antibody against Rac1 (BD
Transduction Labs).
Total Rac1 was detected in samples from corresponding cell
lysates. Immunoblots were scanned using an Epson scanner
(model 2450) and the intensity of each of the active Rac1 bands
and total cellular Rac1 bands were calculated using NIH Image J
software. The fraction of Rac1 that was bound to GTP, or the
relative Rac1 activity was obtained by normalizing signal from the
GST-PBD pull down assay to the total Rac1 band from the
corresponding sample using a software-based algorithm.
Immunoprecipitation
MEF were co-transfected with a Rac1 construct (EGFP-Rac1-
WT or EGFP-Rac1-Y64F) and either Flag-bPIX, Myc-Tiam1, or
Myc-RhoGDI. Two days after transfection, cells were washed with
ice-cold PBS buffer and then extracted using modified RIPA
buffer (0.1% DOC, 0.1% Triton X-100, 2 mM EDTA, 1 mM
PMSF, 2 mM sodium vanadate, 20 mg/ml leupeptin, 20 mg/ml
aprotinin in PBS). Cell lysates were clarified by centrifugation at
,15,000 x g at 4
oC for 10 minutes, and lysate volumes were
normalized for equal protein content using the bicinchoninic assay
(Pierce, Rockford, IL). Lysates containing 800 mg of protein were
equalized for volume with lysis buffer and incubated at 4
oC with
rotation with anti-GFP antibody and then with protein A
sepharose beads (Jackson) to immunoprecipitate EGFP-Rac1-
WT or EGFP-Rac1-Y64F. Proteins were released from the beads
by boiling in Laemmli sample buffer, subjected to SDS-PAGE
using 4–15% gradient polyacrylamide gels, and transferred to
nitrocellulose membranes for Western blotting. The membranes
were probed with anti-GFP to determine the immunoprecipitated
EGFP-Rac1 protein level and then with anti-Flag or anti-Myc to
determine the differences in binding with Flag-bPIX, Myc-Tiam1,
or Myc-RhoGDI.
PAK-binding assays
GST-Rac1 fusion proteins on sepharose beads were washed
once with and then resuspended in 500 ml of lysis buffer without
MgCl2, (50 mM Tris (pH 7.6), 500 mM NaCl, 1% Triton, 0.5%
DOC, 0.1% SDS, 10 mg/ml leupeptin, 10 mg/ml aprotinin,
1 mM PMSF, 0.5 mM sodium vanadate). EDTA was added to
the beads slurry at a final concentration of 10 mM and mix well to
dissociate nucleotide from the Rac1 fusion protein. GTPcS
(0.1 mM; Sigma) was then added to the bead slurry and incubated
for 30 min at room temperature with gentle shaking. A final
concentration of 10 mM MgCl2 was added to stop the GTPcS
loading process. Beads were washed three times with RIPA buffer
and then added to 500 mg of HUVEC protein lysates in RIPA
buffer and incubated at 4
oC for an hour. PAK from HUVEC
protein lysates that was pulled down by the GTPcS-loaded GST-
Rac1 fusion proteins was revealed by immunoblotting with anti-
PAK antibody. The total loading of the fusion proteins was
determined by coomassie blue staining.
In vitro kinase assays
Escherichia coli BL21 (Stratagene) were transformed with GST,
GST-tagged Rac1-WT or Rac1-Y64F DNA constructs. GST and
the GST-Rac1 fusion proteins were purified from bacterial lysates,
immobilized on glutathione-sepharose beads, and then released
with elution buffer (50 mM Tris, pH 8.0, 10 mM reduced
glutathione; Sigma, St. Louis, MO) and quantified using Pierce
Coomassie protein reagent (Fisher Scientific, Hampton, NH).
Approximately 5 mg of GST, GST-Rac1-WT or GST-Rac1-Y64F
were incubated with differential amounts of purified, baculovirus-
derived Src (aa 86-536), or GST-tagged wild-type FAK (GST-
Tyrosine Phosphorylation of Rac1
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kinase buffer (50 mM Tris, pH 7.4, 5 mM MnCl2, and 5 mM
MgCl2). The total volume of each reaction was adjusted to 60 ml
and samples were incubated at 37
oC for 30 min with occasional
shaking to keep the beads in suspension. The kinase reactions were
stopped by the addition of sample buffer [24], analyzed using
SDS-PAGE, transferred to nitrocellulose, and serially immuno-
blotted with antibodies against GST, Rac1, Src or FAK, and
phosphotyrosine.
Statistical Analysis
The student t-test (two-tailed) was used to analyze cell surface
area, the percentage of the focal adhesion area occupied by Rac1,
Rac1 binding to GTP, and Rac1 binding to Flag-bPIX, Myc-
Tiam1 and Myc-RhoGDI. P values are supplied in each figure
legend, and significance was adjudged to be present at p values less
than 0.05 for all data. All graphs include standard error bars.
Results
Cells expressing Rac1-Y64D and Rac1-Y64F exhibit
changes in spreading and lamellipodial dynamics
The present study was motivated by our previously findings that
FAK-mediated tyrosine phosphorylation of bPIX enhanced both
guanine nucleotide exchange on Rac1 and cell spreading [21],
together with findings of Tu and Cerione on the effects of tyrosine
phosphorylation of Cdc42 at Y64 and the sequence identity
between Cdc42 and Rac1 at this region of Rac1 (Figure 1). We
therefore studied cell spreading and membrane extension kinetics
in cells expressing Rac1 mutations that either obviate tyrosine
phosphorylation at Y64 or mimic constitutive phosphorylation at
this position. The hypothesis at this stage was that tyrosine
phosphorylation would augment Rac1 activity and membrane
extension. A site-directed mutagenesis strategy was used to
produce Y64F and Y64D mutations in EGFP-Rac1.
Consequences of these mutations were studied in HUVEC
(Figure 2A). After 90 min of adhesion to fibronectin-coated glass
coverslips, cells were fixed and prepared for epifluorescence
analysis. Surface area data were calculated from 2-D images of
paraformaldehyde-fixed cells using an algorithm in Openlab
software after labeling with rhodamine-conjugated phalloidin.
EGFP-transfected cells did not spread differently than control non-
transfected HUVEC at this time point. Strikingly, in HUVEC
transfected with EGFP-Rac1-Y64D that mimics a constitutively
phosphorylated tyrosine at position 64, the mean surface area
decreased markedly. Also of note was the large increase in average
cell surface area at 90 min over controls in EGFP-Rac1-Y64F-
transfected HUVEC.
MEF expressing these mutants or Rac1-61L or Rac1-17N were
analyzed for spreading after seeding on FN-coated coverslips for
2 hr was determined by using the method described above, and
data are shown in Figure 2B and 2C. Numerical results and
sample sizes for each experimental group are detailed in Table 1.
Expression of EGFP-Rac1-Y64D reduced spreading by over 50%
as compared with MEF expressing EGFP-Rac1-WT, while EGFP-
Rac1-Y64F expression increased spread cell surface area by 75%
of the control value.
To further investigate the interaction of phosphotyrosine-based
regulation of Rac1 function with the biology of constitutively
active (61L) or dominant negative (17N) changes in Rac1 function,
four additional constructs were produced with double mutations -
EGFP-Rac1-61L/64F, EGFP-Rac1-61L/64D, EGFP-Rac1-17N/
64F, and EGFP-Rac1-17N/64D. These data are shown in Figure 2
B and D, and details are tabulated in Table 1. Rac1-61L-induced
MEF spreading was inhibited in cells expressing the double
mutant 61L/64D, but increased in MEF expressing 61L/64F. In
the case of MEF that were expressing EGFP-Rac1-17N, double
mutant 17N/64D expression caused a further decrement in cell
spreading as compared with cells expressing Rac1-17N, whereas
transfectants expressing EGFP-Rac1-17N/64F exhibited partial
rescue of cell spreading function as compared with MEF
expressing Rac1-17N alone. Thus, the addition of either the
Y64D or the Y64F mutations made a statistically significant
impact in the spreading behavior of MEF expressing either Rac1-
61L or Rac1-17N. These data indicated that tyrosine phosphor-
ylation at Y64 may be a negative regulatory input for membrane
extension that has a separate mechanism from the status of GTP-
binding.
MEF expressing EGFP-Rac1-Y64D were rounded and not well
flattened. They had focal adhesions around the cell periphery but
not focal complexes or well-developed lamellipodia (Figure 2C).
On the contrary, EGFP-Rac1-Y64F, established broad curvilinear
lamellipodia and prominent peripheral focal complexes. The
enhanced cell spreading noted in MEF that were expressing
EGFP-Rac1-61L was further augmented by the addition of the
Y64F mutation without dramatic effect on focal adhesion or focal
complex morphology. The addition of the Y64D mutation, on the
other hand, reduced focal complex number, peripheral focal
adhesions, and cell spreading in both the Rac1-61L and the Rac1-
17N backgrounds. The absence of apoptosis in MEF expressing
EGFP-Rac1-Y64D was shown by the absence of caspase 3
cleavage in all 9 of the cells studied (Figure S1). In contrast, all 11
of the H2O2-treated MEF studied were positive for cleaved
caspase 3.
Kymography was then used to study the rate of membrane
extension and lamellipodial persistence in HUVEC that were
expressing EGFP, EGFP-Rac1-Y64D or EGFP–Rac1-Y64F
(Figure 3)[25]. Forty-eight hours following transfection, HUVEC
cells were plated on FN-coated 35-mm glass bottom dishes for 10
minutes, and then studied by phase contrast microscopy at 20
seconds intervals for 20 minutes. Line scans corresponding to the
presented kymographs are shown on the phase image in Figure 3A.
These studies revealed two key insights. First, expression of the
Rac1-Y64F mutation was associated with an increase in the rate of
membrane extension as compared to the control, and intermittent
retraction of the lamellipodial edge seemed to occur less
frequently. An average membrane extension rate of 0.934 mm/
min was observed for Rac1-Y64F-transfected cells, as compared
with 0.294 mm/min for EGFP-transfected HUVEC. In the Rac1-
Y64D-transfected cells, the rate of membrane extension was only
0.039 mm/min. Second, the leading edges of HUVEC expressing
EGFP-Rac1-Y64D were more active than the wild type controls,
and demonstrated very rapid membrane movements. These were
characterized by short-lived protrusions that were quickly and
almost completely retracted, and a failure of these cells to establish
and maintain consistent lamellipodia. On average, there was one
cycle of brief rapid extension followed by quick retraction every
2.5 min in the cells expressing Rac1-Y64D. This pattern of
extension and retraction of the leading membrane edge was also
observed in the EGFP-transfected control cells within the first
5 min of plating, but this behavior quickly disappeared and stable
lamellipodia were then established. In contrast, EGFP-Rac1-
Y64D-transfected cells continued to exhibit this pattern of rapid
and extension and retraction with little spreading at 60 minutes
following plating. In Rac1-Y64F-transfected cells, stable lamelli-
podial extension began immediately after cell attachment to
matrix. Statistical analysis of multiple cells and kymographs for
Rac1-WT, -64F, or -64D transfectants are shown in Figure 3B,
Tyrosine Phosphorylation of Rac1
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minutes and then fixed and permeabilized for immunofluorescence staining. Rhodamine-phalloidin labeled EGFP-positive cells were used for cell
surface area quantification using Openlab software. Data are shown as mean6SEM, and were as follows: non-transfected HUVEC controls had a mean
surface area of 7760 mm
2 (6 730.5, n=28), and the mean area was 6510 mm
2 (61433.0, n=8) for EGFP-transfected cells. A large increase in spread
surface area to 10246 mm
2 (61310, n=14) was noted in EGFP-Rac1-Y64F-transfected HUVEC, and cells expressing EGFP-Rac1-Y64D had a greatly
reduced mean surface area of 1480 mm
2 (61037, n=5). ** indicates p ,0.001, and *** denotes p , 0.0001 for the designated population as
compared with the EGFP control. (B) Cell surface area was quantified from phalloidin-labeled MEF images using Openlab software in cells transfected
with EGFP-Rac1-WT, EGFP-Rac1-Y64F, EGFP-Rac1-Y64D, EGFP-Rac1-61L, EGFP-Rac1-61L/64F, EGFP-Rac1-61L/64D, EGFP-Rac1-17N, EGFP-Rac1-17N/
64F, or EGFP-Rac1-17N/64D. Data are shown as the mean6SEM. * denotes p , 0.05, ** means p ,0.001, and *** is p , 0.0001 when data from
groups transfected with Y64F or Y64D are compared with values from the corresponding controls (e.g. EGFP-Rac1-WT, EGFP-61L, or EGFP-17N,
respectively, without the mutations at position 64). ## denotes p,0.005, while ### denotes p,0.0001 when data from 61L or 17N mutants were
compared with wild-type. Quantitative cell spreading data and the number of MEF studied in each group are detailed in Table 1. (C) MEF were
transfected with EGFP, or EGFP-tagged Rac1 single mutants. Two days after transfection, cells were seeded onto fibronectin-coated coverslips for two
hours and prepared for immunofluorescence analysis. Cells were labeled with DAPI, rhodamine-phalloidin and anti-vinculin (followed by Cy5).
Transfected GFP-positive cells are shown indicated in black and white, while the composite images display merges of combined DAPI (blue),
phalloidin (red) and vinculin (green) labeling. Scale bar denotes 20 mm. (D) MEF that had been transfected with the EGFP-tagged Rac1 double
mutants including Rac1-61L/64F, -61L/64D, -17N/64F, or -17N/64D were plated on fibronectin-coated coverslips and labeled for IF analysis as describe
for panel 2C. Scale is the same as panel 2C.
doi:10.1371/journal.pone.0028587.g002
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Transfected Construct Number of Cells Mean Surface Area (mm
2) Standard Error
EGFP 38 1666 133.7
61L 28 3448 422.2
17N 18 751.8 88.79
64F 26 2930 290.1
64D 32 791.8 80.03
61L/64F 23 4052 324.3
61L/64D 20 1627 143.6
17N/64F 21 1229 152.84
17N/64D 34 523.4 79.68
doi:10.1371/journal.pone.0028587.t001
Figure 3. Expression of Rac1-Y64F or Rac1-Y64D altered lamellipodial dynamics. HUVEC cells were transfected with EGFP, or EGFP-tagged
Rac1-Y64D, or Rac1-Y64F. Cells were plated onto fibronectin-coated coverslips two days after transfection, and were observed under phase contrast
microscopy until initial attachment was achieved (typically 10 minutes). Images were taken every 20 seconds for 20 minutes. Kymograph analysis of
cell spreading efficiency was performed using these serial images. (A) Three sets of kymographs are shown from each transfected cell: a–c for EGFP-
Rac1-Y64F; d-f for EGFP and g-i for EGFP-Rac1-Y64D. The lower panel shows the transfected cells that were studied with the line scan used for
kymograph. The inset shows the GFP signal of the transfected cells. (B) Kymography from three to six transfected cells were analyzed to study the
differences in their spreading. Significant differences in lamellipodial extension were noted in both cells expressing Rac1-Y64F and Rac1-Y64D when
compared with HUVEC expressing Rac1-WT (p values = 0.0377 and 0.0005 respectively).
doi:10.1371/journal.pone.0028587.g003
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S2. These findings suggest a role for tyrosine phosphorylation in
the modulation of Rac1 function during the stabilization of
cytoskeletal infrastructure and/or transmembrane adhesions
during cell spreading and movement.
Focal Adhesion targeting of Rac1 is modulated by Y64
phosphorylation
Our previous work documented activity-dependent targeting of
Rac1 to focal adhesions [21]. In order to investigate the effects of
Y64phosphorylationonthesubcellulartargetingofactiveRac1,the
spatial localization of EGFP-Rac1-61L, EGFP-Rac1-61L/64F and
EGFP-Rac-61L/64D were analyzed in transfected HUVEC
(Figure 4, A and B). After 90 minutes of adhesion to fibronectin-
coated glass coverslips, both EGFP-Rac1-61L and EGFP-Rac1-
61L/64F exhibited a high degree of targeting to vinculin-containing
focal adhesions, with average values of 50.56615.01% and
53.70%611.03% respectively. However, the activation-driven
effects of the 61L state on Rac1 targeting was apparently
antagonized by the simultaneous expression of Y64D, such that
only20.19619.39% of focal adhesion areawas occupied byEGFP-
Rac1-61L/64D. These data suggest a role for tyrosine phosphor-
ylation at Rac1-Y64 in the regulation of Rac trafficking to matrix
adhesion sites.
Mutations at Rac1-Y64 change binding and association
with GTP, GEFs, PAK, and RhoGDI
To further elucidate the molecular mechanisms of Rac1-Y64F
enhancement of cell spreading, lamellipodial stability, and the
targeting of Rac1 to focal adhesions, we studied Rac1 activity (e.g.
GTP binding and not GTPase activity) in MEF that were
transfected with EGFP-Rac1-WT, or mutations that included
Q61L, T17N, Y64D, or Y64F (Figure 5). Rac1 activity was
analyzed in aliquots of lysates from transfected MEF by a GST
affinity pull-down assay using the Rac-binding domain of PAK
and 15 mg of protein from each sample were blotted with anti-
Figure 4. Y64 phosphorylation modulated focal adhesion targeting of active Rac1. (A) HUVEC cells were transfected with EGFP-tagged
Rac1 mutants including Rac1-61L, Rac1-61L64F and Rac1-61L64D. Cells were labeled with DAPI and anti-vinculin (followed by Cy5). Transfected EGFP-
positive cells are shown in green, while the vinculin labeled focal adhesions shown in red. The composite images display merges of combined GFP
(green), DAPI (white), and vinculin (red) labeling. The boxed areas were magnified (2X) and shown in the insets. Scale bar denotes 30 mm. (B) The
percentage of the total focal adhesion area (defined by vinculin labeling) that was occupied by EGFP-tagged Rac1 mutants in transfected cells were
quantified using Openlab software. Fifteen randomly picked transfected cells were analyzed in each group, and data are shown as the mean6SD. *
denotes p , 0.05 when data from groups transfected with 61L/64F or 61L/64D are compared with values from the group transfected with 61L alone.
doi:10.1371/journal.pone.0028587.g004
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expressed fairly comparable amounts of the respective EGFP-
tagged Rac1 proteins, wild type or mutants, except for EGFP-
Rac1-Y64D, which appeared to be quickly degraded. When
800 mg of total protein lysates were reacted in vitro with 50 mgo f
GST-PBD produced in E. coli, the controls were as expected: more
amount of the constitutively active Rac1-61L was pulled down as
compared to the wild type, and no dominant negative Rac1-17N
was pulled down. Interestingly, more of the EGFP-Rac1-Y64F was
pulled down by GST-PBD than the wild type Rac1, indicating
more GTP binding and higher Rac1 activity in the presence of the
Y64F mutation (Figure 5A). The degraded EGFP-Rac1-Y64D
product did not bind to GST-PBD indicating a decrease in both
GTP binding and Rac1 activity. Densitometry data from four sets
of these experiments are shown in Figure 5B. GTP-bound active
Rac1 in the pull downs was normalized to the amount found by
Western blot in total lysates. A 3.5 fold increase in Rac1 activity
was observed for the EGFP-Rac1-Y64F mutant compared to the
wild type. Interestingly, in the background of the constitutively
active 61L mutation, 64F and 64D mutations also affected Rac1
activity. Unlike the single mutation EGFP-Rac1-Y64D which was
degraded in transfected cells, EGFP-Rac1-61L/64D was more
stable. EGFP-Rac1-61L/64D had lower Rac1 activity than either
the 61L or 61L/64F mutants (Figure 5C and D).
Figure 5. Mutations in Rac1-Y64 changed binding to GTP. (A) Left panel: MEF cells were transfected with Rac1 mutants including EGFP-Rac1-
61L (lane 1 EGFP-Rac1-17N (lane 2), EGFP-Rac1-Y64D (lane 3), or EGFP-Rac1-Y64F (lane 4), or with EGFP (lane 5), or EGFP-Rac1-WT (lane 6). Coomassie
blue staining of the membrane (bottom row, left) verified the addition of an equal amount of PBD-GST. Western blotting was done using both anti-
Rac1 and anti-GFP antibodies. Right panel: 15 mg of total protein lysates were also analyzed by SDS-PAGE and immunoblotted to verify equal loading
and the expression of the transfected EGFP-Rac1 constructs. (B) Four sets of Rac1 activity assay results were used for densitometry and statistical
analysis of the difference in activity between Rac1-WT and Rac1-Y64F. Western blots were scanned and Rac1 activity was normalized to the total
cellular Rac1. Data shown are mean values6SEM. * denotes p , 0.02. (C) Protein lysates were harvested from MEF (lane 1) or MEF that were
transfected with EGFP-Rac1WT (lane 2), EGFP-Rac1-61L (lane 3), EGFP-Rac1-61L/64F (lane 4), or EGFP-Rac1-61L/64D (lane 5). PBD-GST pull down
assays were performed with 800 mg of total protein to determine Rac1 activity. The membrane was immunoblotted with anti-Rac1 to demonstrate
the level of Rac1 activity, and was then stained with Coomassie blue to ascertain the relative amounts of PBD-GST substrate added to each sample.
Expression efficiency of the wild type and mutant EGFP-Rac1 constructs was assayed using 15 mg of total protein from whole cell lysates and the Rac1
activity was normalized to the respective protein level of each sample. (D) Five sets of experimental data were analyzed to examine the differences
between the Rac1 activity in lysates from MEF expressing EGFP-RacWT, EGFP-Rac1-61L, EGFP-Rac1-61L/64F, and EGFP-Rac1-61L/64D. ECL blots were
scanned and analyzed using Image J software. The intensity of each of the active Rac1 bands pulled down by PBD was normalized to the total cellular
Rac protein band and calculated by a software-based algorithm. The Rac1 activity in lysates from cells expressing EGFP-Rac1-61L was assigned a
relative value of 100%. ## indicated a significant decrease of Rac1 activity in 61L/64D compared with 61L (p , 0.01). * indicated a significant
increase in Rac1 activity in 61L, 61L/64F and 61L/64D compared with Rac1 wild-type (p . 0.001).
doi:10.1371/journal.pone.0028587.g005
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affected the association of Rac1 with two Rac1-associated GEF
proteins that can perform nucleotide exchange on Rac1 - bPIX
and Tiam1 (Figure 6). MEF cells were co-transfected with either
EGFP-Rac1-WT or EGFP-Rac1-Y64F, and with either Flag-
tagged bPIX or Myc-tagged Tiam1. The EGFP-Rac1 constructs
were immunoprecipitated with anti-GFP antibody and immuno-
blotting with anti-Flag or anti-Myc antibodies was used to
interrogate the amounts of Flag-bPIX or Myc-Tiam1 that bound
to the respective EGFP-Rac1 proteins. The Y64F mutant doubled
Rac1 interaction with bPIX (Figure 6, A and B), but the data on
Tiam1 association revealed an increase in association with EGFP-
Rac1-Y64F as compared with the wild type EGFP-Rac1 that did
not reach statistical significance (Figure 6, C and D). These data
suggest that increased association with GEFs may contribute to
increased GTP loading on Rac1-Y64F, and to the increased
spreading seen in cells expressing this construct.
To test the impact of Rac-1-Y64D or Y64F expression on Rac1
interaction with its molecular effectors, PAK-binding assays were
performed (Figure 7). Purified GST-tagged Rac1-WT, Rac1-17N,
and the previously detailed mutants were isolated on sepharose,
loaded with non-hydrolyzable GTPcS, and incubated with native
PAK from HUVEC lysates. Rac1-17N did not bind to PAK,
whereas Rac1-64D exhibited decreased binding compared with
Rac1-WT, -61L, or -64F. This finding indicates that phosphor-
ylation of tyrosine at position 64 in Rac1 may downregulate, but
not abrogate, Rac1 binding to both GTP and PAK.
Finally, since RhoGDI binding may regulate subcellular
trafficking, sequestration and interactions with downstream
substrates for Rho family GTP binding proteins, we examined
RhoGDI-binding in EGFP-Rac1-Y64F as contrasted with wild-
type Rac1 [11]. A representative study and a compilation of five
sets of data from these experiments are shown in Figure 8. A
greater than 50% drop in RhoGDI binding was associated with
expression of the Y64F mutation in EGFP-Rac1.
Both Src and FAK phosphorylate Rac1 at tyrosine 64
Src and FAK have been shown to function cooperatively in the
tyrosine phosphorylation of downstream substrate proteins during
integrin signaling [26–30]. In order to ascertain whether Src and
Figure 6. The Y64F mutation in Rac1 changed binding to guanine nucleotide exchange factors. (A) Protein lysates were harvested from
MEF that were co-transfected with Flag-tagged bPIX, and either EGFP-tagged Rac1WT (lane 1) or Rac1-Y64F (lane 2). Ectopically expressed EGFP-Rac1
proteins, wild-type or Y64F mutant, were immunoprecipitated with anti-GFP antibody and the membrane was blotted with anti GFP to demonstrate
the expression level of EGFP-Rac1 proteins and also with anti-Flag antibody to reveal the Flag-bPIX that was co-immunoprecipitated with EGFP-Rac1
proteins. Immunoblotting of total cell lysates (TCL) for Flag-bPIX and EGFP-Rac1 are shown below the co-immunoprecipitation study as controls. (B)
Four sets of experimental data were analyzed for the differences in binding to Flag-tagged bPIX for EGFP-Rac1WT or EGFP-Rac1-Y64F. The intensity of
the co-immunoprecipitated Flag-bPIX was normalized to the EGFP-Rac1 pulled down by anti-GFP antibody. The amount of Flag-bPIX co-
immunoprecipitated with EGFP-Rac1WT was assigned a relative value of 100%. EGFP-Rac1-Y64F bound more efficiently to Flag-bPIX (p = 0.0223). (C)
Protein lysates were harvested from MEF that were co-transfected with Myc-tagged Tiam1 and either EGFP-Rac1WT (lane 1) or EGFP-Rac1-Y64F (lane
2). Ectopically expressed EGFP-Rac1 proteins were immunoprecipitated with anti-GFP antibody and the membrane was blotted with anti GFP to
demonstrate the expression level of EGFP-Rac1 proteins, and with anti-Myc antibody to reveal the Myc-Tiam1 that was co-immunoprecipitated with
the EGFP-Rac1 constructs. Immunoblotting of total cell lysates (TCL) for Myc-Tiam1 and EGFP-Rac1 are shown below the co-immunoprecipitation
study as controls. (D) Six sets of experimental data were analyzed for differences in binding to Myc-Tiam1 between EGFP-Rac1WT and EGFP-Rac1-
Y64F. The intensity of the immunoprecipitated Myc-Tiam1 was normalized to the EGFP-Rac1 pulled down by anti-GFP antibody. The amount of Myc-
Tiam1 co-immunoprecipitated with EGFP-Rac1WT was assigned a relative value of 100%. The difference did not reach statistical significance
p = 0.3793).
doi:10.1371/journal.pone.0028587.g006
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vitro kinase assays were performed (Figure 9A and B). Five mgo f
purified GST-Rac1 were incubated with increasing amounts of
human Src (aa 86-536) (0, 0.25, 1 and 4 mg) or GST-FAK (aa
411–686) (0, 0.5, 1.5 and 2.5 mg) in kinase buffer with or without
ATP (for the Src assay). Kinase reaction mixtures were then
separated by SDS-PAGE and blotted with anti-Src, anti-GST, and
anti-phosphotyrosine to determine the kinase activity of Src and
FAK on Rac1 tyrosine phosphorylation (Figure 9). Five mg of GST
were used as a control substrate. The results demonstrated that
specific, dose-dependent phosphorylation of GST-Rac1 was
mediated by both Src and FAK. The absence of tyrosine
phosphorylation when GST was used as substrate indicated that
Rac1, and not the GST tag, was the phosphorylation target.
Src has previously been shown to phosphorylate Cdc42 on
tyrosine 64, and pY64-Cdc42 showed stronger binding affinity to
RhoGDI than non-phosphorylated Cdc42 [20]. Analysis with the
phosphorylation site module of the prediction program PHOSIDA
(www.phosida.com) [31] identified Y64 as one of the two major
candidate phosphorylation sites on Rac1. Therefore, Tyr64 was
changed to Phe64 using site-directed mutagenesis in order to study
the role of this residue in the process of Rac1 phosphorylation by
Src or FAK in vitro. Five mg of purified GST-Rac1 or GST-Rac1-
Y64F were incubated with 0, 1, or 3 mg of purified Src or GST-
FAK in kinase buffer with or without ATP. Resulting kinase
reaction mixtures were subjected to SDS-PAGE and immuno-
blotted with antibodies against Src, GST, and phosphotyrosine
(Figure 9C and D). This analysis demonstrated equal loading of
GST-Rac1 and GST-Rac1-Y64F in the kinase reaction mixtures
(lower panel of Figure 9C and D; FAK used in this kinase assay
was also tagged with a GST, and thus revealed in the GST blot).
Anti-Src immunoblots showed a doublet (middle panel in
Figure 9C) - the upper band of the doublet is tyrosine-
phosphorylated Src and the lower band of the doublet is non-
tyrosine-phosphorylated Src. Dose-dependent, specific tyrosine
phosphorylation of GST-Rac1 that required ATP was seen with
both Src and FAK, but tyrosine phosphorylation by either Src or
FAK was all but abolished on GST-Rac1-Y64F (Figure 9, C and
D). These data indicate that a specific, dose-dependent tyrosine
phosphorylation of Rac1 at Y64 by both FAK and Src may occur
in vitro.
Src mediates tyrosine phosphorylation of Rac1 in MEF
To test whether Src can specifically tyrosine-phosphorylate
Rac1 in vivo, SYF (triple knock out) cells were transfected with
EGFP-tagged wild-type Rac1 alone, or together with either wild-
type Src or kinase dead Src. Ectopically expressed EGFP-Rac1
was immunoprecipitated with anti-GFP antibody and blotted with
anti-phosphotyrosine antibody to determine the tyrosine phos-
phorylation level of the EGFP-Rac1. Immunoblotting of these
same membranes with anti-GFP or anti-Rac1 antibodies provided
a measure of the expression level of EGFP-Rac1. Our results
showed that expression of the full length EGFP-Rac1 (,48.4 kDa)
was not affected by singular transfection or double transfection
with Src. Interestingly the EGFP-Rac1 when transfected alone or
with a kinase-dead Src was not tyrosine phosphorylated. Only
when SYF cells were co-transfected with wild-type Src, was the
EGFP-Rac1 phosphorylated on tyrosine (Figure 10).
Discussion
Tyrosine phosphorylation events drive many essential events in
the life of eukaryotic cells, and the nonreceptor tyrosine kinases
FAK and Src have diverse roles in developmental, vascular, and
cancer biology [26,30,32–36]. The current investigations contrib-
ute additional facets to the understanding of phosphotyrosine
signaling and identify a new possible regulatory input in the
Figure 7. The Rac1-64D mutation caused decreased Rac1
binding to PAK. 30 mg of purified GST-tagged Rac1 17N (lane 1),
wild-type (lane 2), 61L (lane 3), 64D (lane 4) or 64F (lane 5) were bound
to sepharose beads and loaded with GTPcS for 30 min before
incubation with 400 mg of HUVEC protein lysates in order to assay
PAK binding. Unlike the 17N mutant which can not bind GTP, Rac1-64D
does bind GTP and pull down PAK. However, PAK binding by this
mutant is reduced compared to that seen for Rac1-WT, -61L, or -64F.
doi:10.1371/journal.pone.0028587.g007
Figure 8. The Y64F mutation in Rac1 decreased binding to RhoGDI. (A) Protein lysates were harvested from MEF that were co-transfected
with Myc-tagged RhoGDI and either EGFP-tagged Rac1WT (lane 1) or Rac1-Y64F (lane 2). EGFP-Rac1WT or EGFP-Rac1-Y64F proteins were
immunoprecipitated with anti-GFP antibody and the membrane was blotted first with anti-GFP to demonstrate the expression level of EGFP-Rac1
proteins, and then with anti-Myc antibody to show the Myc-RhoGDI that co-immunoprecipitated with EGFP-Rac1 proteins. Immunoblotting of total
cell lysates (TCL) for Myc-RhoGDI and EGFP-Rac1 are shown below the co-immunoprecipitation study as controls. (B) Five sets of experimental data
were analyzed for the differences between EGFP-Rac1WT and EGFP-Rac1-Y64F interaction with Myc-RhoGDI. ECL blots were scanned, normalized,
and analyzed as described above. Myc-RhoGDI bound less well to EGFP-Rac1-Y64F as compared to EGFP-Rac1WT (p = 0.011).
doi:10.1371/journal.pone.0028587.g008
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of cytoskeletal responses to the cellular microenvironment. The
data presented here suggest structure-function relationships within
the Rac1 Switch II domain that may be altered by tyrosine
phosphorylation and change Rac1-mediated cytoskeletal dynamics
during cell spreading.
Tyrosine 64 is located in the Switch II domain of Rac1 - one of
two regions that are distinguished by conformational differences
between the GDP-bound (inactive) and the GTP-bound (active
Rac1) states [37]. The conformational sensitivity of this location
and its susceptibility to phosphorylation strongly suggest its
importance in regulating Rac1 function. Modeling and experi-
ments by others implicate it directly in the regulation of Rac1
activation by nucleotide exchange, and in similar events for Ras
[37–40]. Our data indicate that Y64 phosphorylation provides a
negative input on GTP-binding and cell spreading (Figures 5 and
2, respectively). Interestingly, X-ray crystallography of the Cdc42-
RhoGDI complex shows that the Y64 of Cdc42 is in close
proximity to lysine residues at positions 43 and 52 of RhoGDI. It is
believed that the negative charge induced by tyrosine phosphor-
ylation at Y64 could stabilize the interaction with these two
positively charged basic residues on RhoGDI [15,20]. This
hypothesis is supported by our finding that the Rac1-Y64F
mutation weakened Rac1 interaction with RhoGDI (Figure 8).
Experimental probing for potential interactions between
tyrosine phosphorylation and either constitutive or dominant
negative changes in Rac1 activation indicate that there may be
separable and combinatorial actions of these two signaling
mechanisms with regard to GTP loading, Rac1 targeting to focal
adhesions, and cell spreading. The 3-fold increase in GTP loading
on Rac1-Y64F as compared with the wild type may be due in part
to the fact that the Rac1-Y64F mutant binds more efficiently with
Rac1-associated GEFs (Figure 6). Thus, we note an 89% increase
in binding with b-PIX, and a more difficult to quantify increase in
binding to Tiam1 for Rac1-Y64F as compared with Rac1-WT.
Further, the Rac1-Y64D mutant that mimics a constitutively
phosphorylated state appears to exert a downward regulatory
effect on GTP loading, focal adhesion targeting, and cell spreading
Figure 9. Src and FAK mediated tyrosine phosphorylation of Rac1 at tyrosine 64 in vitro. (A) 5 mg of either GST-Rac1 (lanes 1–5) or GST
(lane 6) were incubated with 0 mg (lane1), 0.25 mg (lane 2), 1 mg (lanes 3, 5, 6), or 4 mg (lane 4) of purified Src in kinase buffer. All samples included
20 mM ATP except for the one shown in lane 5. The kinase reaction mixture was analyzed by SDS-PAGE and immunoblotted with antibodies against
phosphotyrosine, Src, and GST. (B) 5 mg of GST-Rac1 (lanes 1–4) or GST (lanes 5–8) were incubated with 0 mg (lanes 4, 8), 0.5 mg (lanes 1, 5), 1.5 mg
(lanes 2, 6), or 2.5 mg (lanes 3, 7) of GST-tagged wild-type FAK (GST-wtFAK411-686) in kinase buffer with 20 mM ATP. The kinase reaction mixture was
analyzed by SDS-PAGE, and immunoblotted with antibodies against phosphotyrosine and GST. (C) 5 mg of GST-Rac1-WT (lanes 1–4) or GST-Rac1-Y64F
(lanes 5–8) were incubated with 0 mg (lanes 1, 5), 1 mg (lanes 2, 6), or 3 mg (lanes 3, 4, 7, 8) of purified Src. Reactions run in all lanes contained 20 mM
ATP, except for lanes 4 and 8. The kinase reaction mixture was analyzed by SDS-PAGE and immunoblotted with antibodies against phosphotyrosine,
Src, and GST. (D) 5 mg of GST-Rac1-WT (lanes 1–4) or GST-Rac1-Y64F (lanes 5–8) were incubated with purified GST-WT-FAK (aa 411-686) in the
following amounts: 0 mg (lanes 1, 5), 1 mg (lanes 2, 6), or 3 mg (lanes 3, 4, 7, 8). All reactions included 20 mM ATP except for the ones represented in
lanes 4 and 8. The kinase reaction mixture was analyzed by SDS-PAGE and immunoblotted with antibodies against phosphotyrosine and GST.
doi:10.1371/journal.pone.0028587.g009
Tyrosine Phosphorylation of Rac1
PLoS ONE | www.plosone.org 11 December 2011 | Volume 6 | Issue 12 | e28587efficiency in both constitutively active and dominant negative
Rac1 mutants. Taken together with the RhoGDI data, these
findings depict a pattern of negative regulation that is a
precedented theme in signaling regulation by tyrosine kinases
and has been demonstrated in the context of FAK interactions
with endophilin A, Src, and MMP-14 [41]. In the case under study
here, down-regulation of Rac1 function by FAK and Src may
directly oppose and thereby modulate the largely positive effects
that these two nonreceptor tyrosine kinases have on lamellipodial
extension by other means, e.g. via bPIX phosphorylation and its
subsequent increased activation of Rac1.
We have previously demonstrated that Rac1 can localize to
focal adhesions and focal complexes at the leading edges of
actively evolving membrane ruffles and lamellipodia [21]. This
localization appeared to be affected by the activation state of
Rac1. MEF expressing the constitutively active Rac1-Q61L
mutant showed good focal adhesion targeting accompanied by
broad lamellipodia and increased cell size, while cells expressing
the dominant negative Rac1-T17N mutant demonstrated the
opposite. Data in the present study show that the Y64F mutation
did not decrease focal adhesion targeting in HUVEC expressing
Rac1-Q61L (Figure 4). In marked contrast, expression of either
Y64D or 61L64D was associated with decrements in focal
adhesion targeting and lamellipodial deployment, and a limitation
of spreading efficiency when compared with cells expressing WT,
61L, or 61L64F Rac1 constructs. Kymography indicated that the
changes in lamellipodial formation and cell spreading may result
from poor stability of these structures – HUVEC that expressed
Rac1-Y64D repeatedly extended lamellipodia, but these structures
could not support cell spreading because they were not persistent
(Figure 3) (see also [25]). These data are consistent with a role for
tyrosine phosphorylation as a negative regulator of the stability of
both Rac1 association with matrix adhesion sites and lamellipodial
extension. Some of these effects may be mediated by changes in
Rac1 interactions with PLCc which has a known role in
lamellipodial extension and persistence [42]. Phe37 and Tyr64
of Rac1 have been shown to bracket Tyr118 of PLC-beta2 to form
a series of off-angle, edge-to-face, p-orbital stacking interactions
[43]. The negative charge introduced by phosphorylation of Y64
could destabilize this interaction and sabotage lamellipodial
development. The PIX- and PAK-binding data presented in
Figures 6 and 7 suggest that destabilization of Rac1-PIX-PAK
complexes could also contribute to these changes in lamellipodial
dynamics (see [21]).
In the context of relatively rapid cycling through phosphory-
lation and dephosphorylation at the leading edge of a spreading or
migrating cell, the negative modulation of adhesion and
lamellipodial stability by events at Rac1-Y64 could serve to
control cell movement and plasticity. Abrogation of phosphory-
lation at this site with the substitution of phenylalanine for tyrosine
increased the rate of lamellipodial extension (Figure 3). However,
the static state of constitutive phosphorylation that is modeled by
the Y64D mutation apparently causes severe limitation of stable
membrane extension and leads to a contracted phenotype
(Figures 2 and 3). This does not, however, immediately trigger
apoptosis (Figure S1). Our hypothesis is that the recovery of pY64-
Rac1 from cells is complicated by the short time scale of the
phosphorylation state, and by the inefficient recovery of Rac1
from cell lysates that is encountered by many workers in this field.
Our investigations of direct interactions between Rac1, Src, and
FAK were motivated by our previous insights into FAK
augmentation of Rac1 activation during cell spreading, and the
Cerione lab’s work on the interactions between Src and Cdc42
[20,21]. The development of purified reagents suitable for the
study of interactions between individual kinase-substrate pairs in
vitro made it possible to define roles for both Src and FAK in the
tyrosine phosphorylation of Rac1 on tyrosine (Figure 9)[22].
Interestingly, these experiments led to identification of Y64 as the
major target tyrosine on Rac1 for FAK and Src. This is only one
of eight tyrosines in the human Rac1 amino acid sequence, and
one of six that are homologous with tyrosine residues in human
Cdc42 (together with Y23, Y32, Y40, Y72, and Y154; see
Figure 1), yet it is identical to the major Src target identified in
Cdc42. In vitro kinase assays showed that when Y64 was mutated
to F64 in GST-Rac1, tyrosine phosphorylation was reduced by
92.8% in assays with FAK as compared with the GST-Rac1-WT,
and by 62.6% in assays with Src. This discrepancy suggests an
interesting difference in the intermolecular interactions between
Rac1 and each of these two nonreceptor kinases. The residual
tyrosine phosphorylation by Src and FAK that were observed
when GST-Rac1-Y64F was used as a phosphorylation substrate
suggest the possibility of other tyrosine phosphorylation targets.
This possibility was further supported by the presence of tyrosine
phosphorylation on EGFP-Rac1-Y64F when it was co-transfected
with wild-type Src into SYF cells (not shown). Analysis using the
online Phosida database identified Y98 as another possible
tyrosine phosphorylation site having specific homology with sites
in other substrates for the kinase ALK (anaplastic lymphoma
kinase). As in the case of Src-mediated effects on Cdc42, the
tyrosine phosphorylation of Rac1 at Y64 changes interactions with
RhoGDI (Figure 8)[20]. Our data indicate that abrogation of Y64
phosphorylation on Rac1 via an Y64F point mutation halves Rac1
association with RhoGDI. By inference, phosphorylation at this
site may facilitate the binding of membrane-bound Rac1 to
Figure 10. Src tyrosine-phosphorylated Rac1 in MEF. (A) SYF
cells were transfected with EGFP- Rac1-WT alone (lane 1) or together
with wild-type Src (lane 2) or kinase dead Src (lane 3). EGFP-Rac1
immunoprecipitates were obtained with anti-GFP antibody two days
after transfection, and immunoblotted with anti-GFP and anti-
Rac1antibodies to quantify EGFP-Rac1 expression, and then with anti-
phosphotyrosine to probe for tyrosine phosphorylation of EGFP-Rac1,
as seen in cells that were transfected with exogenous Src. Molecular
weight markers are shown in kilodaltons (kDa) on the left. (B)
Immunoblotting of total cell lysates (TCL) for EGFP-Rac1 and Src are
shown as a control.
doi:10.1371/journal.pone.0028587.g010
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inhibitory influence on Rac1 activation by interfering with its
release from this complex by diacylglycerol kinase f [44–46].
Taken together, the findings reported here are consistent with a
possible mode of cross-talk between two cytoskeletal regulating
mechanisms that are turned on by integrin engagement during the
early phases of cell attachment and spreading on extracellular
matrix: the nonreceptor tyrosine kinases Src and FAK, and the
Rho family member Rac1. The inhibition of Rac1 by tyrosine
phosphorylation in this context appears to represent an addition to
the checks and balances that control cell shape and volume during
cell spreading.
Supporting Information
Figure S1 Expression of Rac1-64D limits cell spreading
but does not induce apoptosis. A. Caspase 3 cleavage was
quantified by immunofluorescence as a marker of apoptosis in
MEF that were treated for 16 h with 0.5 mM H2O2. All of these
cells were positive (representative cells are shown in the top
panels). Scale bar denotes 20 mm. B. In contrast, all of the Rac1-
64D-transfected MEF cells were negative for cleaved caspase 3
after 24 h of transgene expression (lower panel). GFP-Rac1-64D is
shown in green, anti-cleaved caspase 3 antibody labeling is shown
in blue, phalloidin is shown in red, and DAPI is shown in grey
scale.
(TIF)
Figure S2 HUVEC and line scans used to analyze the
effects of mutant Rac1 on lamellipodial extension. Phase
images are shown of some of the HUVEC transfected with Rac1-
WT, and Rac1-64F, and Rac1-64D that were used for the
kymography analysis shown in Figure 3. The line scans used to
analyze lamellipodial movements are shown for each cell.
(TIF)
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